| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 2.31e-04 | 4 | 125 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA binding | 3.38e-04 | 22 | 125 | 3 | GO:0000062 | |
| GeneOntologyMolecularFunction | spermidine transmembrane transporter activity | 3.84e-04 | 5 | 125 | 2 | GO:0015606 | |
| GeneOntologyMolecularFunction | fatty acid derivative binding | 4.40e-04 | 24 | 125 | 3 | GO:1901567 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA3 SRP54 RECQL BTAF1 MORC4 MORC2 DNAH12 NAV1 MORC3 ATP2B3 | 4.61e-04 | 441 | 125 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | acyl-CoA binding | 5.60e-04 | 26 | 125 | 3 | GO:0120227 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transfer activity | 5.74e-04 | 6 | 125 | 2 | GO:0120019 | |
| GeneOntologyBiologicalProcess | post-embryonic development | 1.58e-05 | 135 | 122 | 7 | GO:0009791 | |
| HumanPheno | Abnormal superficial reflex | AARS1 GRIA3 MORC2 SLC2A1 PNPT1 VPS13D DDHD1 C19orf12 ZFYVE26 ZFHX3 ATP2B3 COQ7 | 7.17e-06 | 301 | 45 | 12 | HP:0031828 |
| HumanPheno | Babinski sign | AARS1 GRIA3 MORC2 SLC2A1 PNPT1 VPS13D DDHD1 C19orf12 ZFYVE26 ZFHX3 ATP2B3 COQ7 | 7.17e-06 | 301 | 45 | 12 | HP:0003487 |
| HumanPheno | Abnormality of proprioception | 5.56e-05 | 157 | 45 | 8 | HP:0010870 | |
| HumanPheno | Impaired proprioception | 5.56e-05 | 157 | 45 | 8 | HP:0010831 | |
| Domain | zf-CW | 6.59e-08 | 7 | 125 | 4 | PF07496 | |
| Domain | ZF_CW | 6.59e-08 | 7 | 125 | 4 | PS51050 | |
| Domain | Znf_CW | 6.59e-08 | 7 | 125 | 4 | IPR011124 | |
| Domain | CRAL-bd_toc_tran | 9.08e-07 | 12 | 125 | 4 | IPR001071 | |
| Domain | CRAL_TRIO_N | 9.08e-07 | 12 | 125 | 4 | SM01100 | |
| Domain | CRAL/TRIO_N_dom | 2.47e-06 | 15 | 125 | 4 | IPR011074 | |
| Domain | GOLD_dom | 6.86e-06 | 19 | 125 | 4 | IPR009038 | |
| Domain | HATPase_c | 6.86e-06 | 19 | 125 | 4 | PF02518 | |
| Domain | GOLD | 6.86e-06 | 19 | 125 | 4 | PS50866 | |
| Domain | - | 8.53e-06 | 20 | 125 | 4 | 3.30.565.10 | |
| Domain | CRAL_TRIO | 1.05e-05 | 21 | 125 | 4 | PF00650 | |
| Domain | HATPase_C | 1.05e-05 | 21 | 125 | 4 | IPR003594 | |
| Domain | - | 1.53e-05 | 23 | 125 | 4 | 3.40.525.10 | |
| Domain | SEC14 | 2.17e-05 | 25 | 125 | 4 | SM00516 | |
| Domain | CRAL_TRIO | 2.98e-05 | 27 | 125 | 4 | PS50191 | |
| Domain | CRAL-TRIO_dom | 3.46e-05 | 28 | 125 | 4 | IPR001251 | |
| Domain | DUF1712 | 4.44e-05 | 2 | 125 | 2 | PF08217 | |
| Domain | DUF719 | 4.44e-05 | 2 | 125 | 2 | IPR007998 | |
| Domain | DUF1712_fun | 4.44e-05 | 2 | 125 | 2 | IPR013176 | |
| Domain | DUF719 | 4.44e-05 | 2 | 125 | 2 | PF05334 | |
| Domain | CRAL_TRIO_N | 4.64e-05 | 11 | 125 | 3 | PF03765 | |
| Domain | EMP24_GP25L | 1.26e-04 | 15 | 125 | 3 | PF01105 | |
| Domain | TF_octamer | 1.33e-04 | 3 | 125 | 2 | IPR000972 | |
| Domain | HATPase_c | 2.22e-04 | 18 | 125 | 3 | SM00387 | |
| Domain | PolyA | 4.39e-04 | 5 | 125 | 2 | SM00517 | |
| Domain | - | 4.39e-04 | 5 | 125 | 2 | 1.10.1900.10 | |
| Domain | PABP | 4.39e-04 | 5 | 125 | 2 | PF00658 | |
| Domain | PABP_1234 | 4.39e-04 | 5 | 125 | 2 | IPR006515 | |
| Domain | PABC | 4.39e-04 | 5 | 125 | 2 | PS51309 | |
| Domain | PABP_HYD | 4.39e-04 | 5 | 125 | 2 | IPR002004 | |
| Domain | Acyl-CoA_DH_CS | 1.55e-03 | 9 | 125 | 2 | IPR006089 | |
| Domain | SAM_MT_PRMT | 1.55e-03 | 9 | 125 | 2 | PS51678 | |
| Domain | Arg_MeTrfase | 1.55e-03 | 9 | 125 | 2 | IPR025799 | |
| Domain | ACYL_COA_DH_1 | 1.93e-03 | 10 | 125 | 2 | PS00072 | |
| Domain | ACYL_COA_DH_2 | 1.93e-03 | 10 | 125 | 2 | PS00073 | |
| Domain | ARM-like | 2.29e-03 | 270 | 125 | 7 | IPR011989 | |
| Domain | Acyl-CoA_dh_N | 2.35e-03 | 11 | 125 | 2 | PF02771 | |
| Domain | - | 3.30e-03 | 13 | 125 | 2 | 1.10.540.10 | |
| Domain | Acyl-CoA_dh_1 | 3.30e-03 | 13 | 125 | 2 | PF00441 | |
| Domain | AcylCoA_DH/ox_N | 3.30e-03 | 13 | 125 | 2 | IPR013786 | |
| Domain | - | 3.83e-03 | 222 | 125 | 6 | 1.25.10.10 | |
| Domain | Acyl-CoA_Oxase/DH_cen-dom | 4.41e-03 | 15 | 125 | 2 | IPR006091 | |
| Domain | AcylCoA_DH/oxidase_NM_dom | 4.41e-03 | 15 | 125 | 2 | IPR009100 | |
| Domain | Acyl-CoA_dh_M | 4.41e-03 | 15 | 125 | 2 | PF02770 | |
| Domain | POU | 5.01e-03 | 16 | 125 | 2 | SM00352 | |
| Domain | POU_dom | 5.01e-03 | 16 | 125 | 2 | IPR000327 | |
| Domain | Pou | 5.01e-03 | 16 | 125 | 2 | PF00157 | |
| Domain | POU_1 | 5.01e-03 | 16 | 125 | 2 | PS00035 | |
| Domain | POU_2 | 5.01e-03 | 16 | 125 | 2 | PS00465 | |
| Domain | POU_3 | 5.01e-03 | 16 | 125 | 2 | PS51179 | |
| Domain | AcylCo_DH/oxidase_C | 5.01e-03 | 16 | 125 | 2 | IPR009075 | |
| Domain | POU | 5.66e-03 | 17 | 125 | 2 | IPR013847 | |
| Domain | MFS | 6.00e-03 | 108 | 125 | 4 | PS50850 | |
| Domain | Lig_chan-Glu_bd | 6.34e-03 | 18 | 125 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 6.34e-03 | 18 | 125 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 6.34e-03 | 18 | 125 | 2 | SM00918 | |
| Domain | Iontro_rcpt | 6.34e-03 | 18 | 125 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 6.34e-03 | 18 | 125 | 2 | IPR001508 | |
| Domain | Lig_chan | 6.34e-03 | 18 | 125 | 2 | PF00060 | |
| Domain | PBPe | 6.34e-03 | 18 | 125 | 2 | SM00079 | |
| Pathway | WP_PPAR_SIGNALING | 1.06e-04 | 67 | 99 | 5 | M39553 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 1.22e-04 | 69 | 99 | 5 | M13088 | |
| Pathway | WP_PPAR_SIGNALING_PATHWAY | 1.59e-04 | 73 | 99 | 5 | MM15995 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 1.76e-04 | 16 | 99 | 3 | MM15048 | |
| Pathway | WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION | 1.76e-04 | 16 | 99 | 3 | MM15841 | |
| Pathway | WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION | 2.13e-04 | 17 | 99 | 3 | M39365 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 2.13e-04 | 17 | 99 | 3 | M5488 | |
| Pathway | WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS | 3.00e-04 | 19 | 99 | 3 | M48049 | |
| Pubmed | 4.64e-08 | 3 | 126 | 3 | 15033454 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | DCAKD RAP1GDS1 TES EMC1 ACADL ACADM ADAM9 NOL6 SRP54 PABPC1 HOOK1 VPS35L MRPS5 UTP20 YIPF3 | 1.06e-07 | 754 | 126 | 15 | 33060197 |
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 17077281 | ||
| Pubmed | Cloning of novel human SEC14p-like proteins: ligand binding and functional properties. | 1.85e-07 | 4 | 126 | 3 | 12757856 | |
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 17428729 | ||
| Pubmed | 4.62e-07 | 5 | 126 | 3 | 14607086 | ||
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 7.88e-07 | 202 | 126 | 8 | 33601422 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | AARS1 RANGAP1 EMC1 NOL6 RECQL APOB API5 CHMP4B PABPC1 SLC2A1 LRPPRC DIMT1 GLYR1 RCL1 UTP20 SLC25A11 ATP2B3 THRAP3 SEC23A | 9.47e-07 | 1425 | 126 | 19 | 30948266 |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.51e-06 | 298 | 126 | 9 | 32353859 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | AARS1 ACADM CETN2 BTAF1 CHMP4B LRPPRC PABPC3 RAB11FIP5 THRAP3 | 3.40e-06 | 329 | 126 | 9 | 34316702 |
| Pubmed | FAM114A1 RANGAP1 CETN2 NOL6 FAM114A2 GRIA3 GRIA4 APOB KLF4 PABPC1 LRPPRC HOOK1 PABPC3 SLC27A1 UGP2 ALDH1A1 ATP2B3 THRAP3 | 4.72e-06 | 1442 | 126 | 18 | 35575683 | |
| Pubmed | Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry. | DCAKD ACADM OXR1 OXCT2 LRPPRC DNAJC28 SCP2 RAB11FIP5 SLC25A11 | 4.76e-06 | 343 | 126 | 9 | 28130547 |
| Pubmed | ACADL ACADM OXCT2 LRPPRC BNIP3L SCP2 TIMM17A MRPS5 ZFHX3 SLC25A11 COQ7 | 4.82e-06 | 542 | 126 | 11 | 14651853 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | GPLD1 ADAM9 ANXA4 STEAP4 APOB GALNT7 CHMP4B PABPC1 SEC14L3 PROM2 PABPC3 UGP2 SMS ALDH1A1 SEC14L2 | 8.10e-06 | 1070 | 126 | 15 | 23533145 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | AARS1 RANGAP1 RAP1GDS1 ANXA4 SRP54 FAM114A2 RECQL CHMP4B PABPC1 SLC2A1 LRPPRC RCL1 UGP2 SCP2 SLC25A11 THRAP3 SEC23A | 9.34e-06 | 1367 | 126 | 17 | 32687490 |
| Pubmed | RANGAP1 ADAM9 GRIA3 GRIA4 DNAJC6 PABPC1 MAPK8IP3 LRPPRC HOOK1 PABPC3 NAV1 PRKCB THRAP3 SEC23A | 1.11e-05 | 963 | 126 | 14 | 28671696 | |
| Pubmed | Human Oct-1L isoform has tissue-specific expression pattern similar to Oct-2. | 1.30e-05 | 2 | 126 | 2 | 12663137 | |
| Pubmed | The FAM114A proteins are adaptors for the recycling of Golgi enzymes. | 1.30e-05 | 2 | 126 | 2 | 39129673 | |
| Pubmed | Elimination of redundant synaptic inputs in the absence of synaptic strengthening. | 1.30e-05 | 2 | 126 | 2 | 22090494 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15831936 | ||
| Pubmed | Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. | 1.30e-05 | 2 | 126 | 2 | 11583619 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 31771949 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 10534404 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 25953895 | ||
| Pubmed | Identification of novel single-stranded DNA binding proteins recognizing octamer motif. | 1.30e-05 | 2 | 126 | 2 | 8185580 | |
| Pubmed | Nucleotide sequence of a mouse testis poly(A) binding protein cDNA. | 1.30e-05 | 2 | 126 | 2 | 1630930 | |
| Pubmed | Developmental expression of poly(A) binding protein mRNAs during spermatogenesis in the mouse. | 1.30e-05 | 2 | 126 | 2 | 7893484 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19020299 | ||
| Pubmed | Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells. | 1.30e-05 | 2 | 126 | 2 | 12670305 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 12144930 | ||
| Pubmed | Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. | 1.30e-05 | 2 | 126 | 2 | 7992055 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 26971890 | ||
| Pubmed | Levels of free PABP are limited by newly polyadenylated mRNA in early Spisula embryogenesis. | 1.30e-05 | 2 | 126 | 2 | 10954604 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 8156594 | ||
| Pubmed | Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4. | 1.30e-05 | 2 | 126 | 2 | 18316356 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 29890823 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 9732454 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 25982116 | ||
| Pubmed | GluA4 is indispensable for driving fast neurotransmission across a high-fidelity central synapse. | 1.30e-05 | 2 | 126 | 2 | 21690196 | |
| Pubmed | 1.64e-05 | 14 | 126 | 3 | 18502258 | ||
| Pubmed | RAP1GDS1 ACADL OXR1 DNAJC6 PABPC1 SLC2A1 MAPK8IP3 LRPPRC PABPC3 SLC27A1 UGP2 NAV1 PRKCB SLC25A11 ATP2B3 THRAP3 SEC23A | 1.68e-05 | 1431 | 126 | 17 | 37142655 | |
| Pubmed | RANGAP1 EMC1 ACADL ACADM GRIA3 GRIA4 MAPK8IP3 LRPPRC ARFGAP3 GLYR1 NAV1 MRPS5 PRKCB SLC25A11 THRAP3 | 1.69e-05 | 1139 | 126 | 15 | 36417873 | |
| Pubmed | 2.20e-05 | 92 | 126 | 5 | 20301317 | ||
| Pubmed | PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking. | 2.51e-05 | 16 | 126 | 3 | 16055064 | |
| Pubmed | AARS1 RANGAP1 NOL6 RECQL PABPC1 PNPT1 LRPPRC GLYR1 RCL1 UTP20 SEC23A | 2.72e-05 | 653 | 126 | 11 | 22586326 | |
| Pubmed | EMC1 CETN2 NOL6 SRP54 API5 MORC2 KLF4 CHMP4B SLC2A1 DIMT1 ARFGAP3 RCL1 MRPS5 UTP20 ZFHX3 SLC25A11 HEATR5B | 2.98e-05 | 1497 | 126 | 17 | 31527615 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RANGAP1 BET1 ADAM9 NOL6 CYP20A1 GOLT1B GALNT7 SLC2A1 SLC27A1 VPS35L CCSER2 RAB11FIP5 MORC3 THRAP3 YIPF3 | 3.17e-05 | 1203 | 126 | 15 | 29180619 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AARS1 RANGAP1 NOL6 SRP54 RECQL PABPC1 SLC2A1 LRPPRC DIMT1 GLYR1 RCL1 UTP20 SLC25A11 THRAP3 ALOX12B SEC23A | 3.21e-05 | 1353 | 126 | 16 | 29467282 |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 26134869 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 16831865 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 11328870 | ||
| Pubmed | The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. | 3.90e-05 | 3 | 126 | 2 | 2905684 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 28463110 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 25034140 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 32160108 | ||
| Pubmed | Positive regulation of the vHNF1 promoter by the orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1. | 3.90e-05 | 3 | 126 | 2 | 8622679 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 18163426 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 10490647 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 12172541 | ||
| Pubmed | SIRT1 Functions as a Negative Regulator of Eukaryotic Poly(A)RNA Transport. | 3.90e-05 | 3 | 126 | 2 | 28756945 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 26843391 | ||
| Pubmed | Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. | 3.90e-05 | 3 | 126 | 2 | 9584182 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 17442950 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 21940797 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 9823775 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 22842522 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 14729950 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 19923370 | ||
| Pubmed | OBF1 and Oct factors control the germinal center transcriptional program. | 3.90e-05 | 3 | 126 | 2 | 33512466 | |
| Pubmed | The mouse Y-box protein, MSY2, is associated with a kinase on non-polysomal mouse testicular mRNAs. | 3.90e-05 | 3 | 126 | 2 | 10076007 | |
| Pubmed | Epab and Pabpc1 are differentially expressed during male germ cell development. | 3.90e-05 | 3 | 126 | 2 | 22814100 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 38254723 | ||
| Pubmed | De novo variants in the PABP domain of PABPC1 lead to developmental delay. | 3.90e-05 | 3 | 126 | 2 | 35511136 | |
| Pubmed | Non-genetic and genetic rewiring underlie adaptation to hypomorphic alleles of an essential gene. | 3.90e-05 | 3 | 126 | 2 | 34528284 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 28397107 | ||
| Pubmed | Epab is dispensable for mouse spermatogenesis and male fertility. | 3.90e-05 | 3 | 126 | 2 | 24599567 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 19710692 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 29578408 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 29701755 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 28635594 | ||
| Pubmed | The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. | 3.90e-05 | 3 | 126 | 2 | 8202368 | |
| Pubmed | Family-wide Characterization of Histone Binding Abilities of Human CW Domain-containing Proteins. | 3.90e-05 | 3 | 126 | 2 | 26933034 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 19217372 | ||
| Pubmed | Epab and Pabpc1 are differentially expressed in the postnatal mouse ovaries. | 3.90e-05 | 3 | 126 | 2 | 25370180 | |
| Pubmed | Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2. | 3.90e-05 | 3 | 126 | 2 | 24367622 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 28611064 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 37665675 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DCAKD AARS1 RANGAP1 EMC1 ADAM9 BTAF1 GALNT7 LRPPRC HOOK1 UTP20 HEATR5B YIPF3 SEC23A | 3.96e-05 | 942 | 126 | 13 | 31073040 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RANGAP1 NOL6 APOB KLF4 CHMP4B PABPC1 LRPPRC DIMT1 GLYR1 RAB11FIP5 UTP20 SLC25A11 THRAP3 | 4.27e-05 | 949 | 126 | 13 | 36574265 |
| Pubmed | DCAKD OXR1 BET1 ADAM9 FAM114A2 GALNT7 SLC2A1 DIMT1 ARFGAP3 MRPS5 SLC25A11 YIPF3 SEC23A | 4.41e-05 | 952 | 126 | 13 | 38569033 | |
| Pubmed | AARS1 FAM114A1 RANGAP1 TES BET1 SRP54 FAM114A2 CHMP4B VPS13D ARFGAP3 | 4.42e-05 | 568 | 126 | 10 | 37774976 | |
| Pubmed | 4.66e-05 | 259 | 126 | 7 | 9811942 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RANGAP1 TES EMC1 NOL6 SRP54 RECQL MORC2 DIMT1 UTP20 SLC25A11 SMS | 5.35e-05 | 704 | 126 | 11 | 29955894 |
| Pubmed | Loss of the PlagL2 transcription factor affects lacteal uptake of chylomicrons. | 6.80e-05 | 22 | 126 | 3 | 17983586 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | DCAKD RANGAP1 POU2F1 POU2F2 RECQL BTAF1 MORC2 GLYR1 UTP20 CHSY3 ATP2B3 THRAP3 | 6.94e-05 | 857 | 126 | 12 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AARS1 EMC1 PABPC1 PTPN3 LRPPRC VPS13D HOOK1 CCSER2 NAV1 RAB11FIP5 MORC3 RASSF8 | 7.25e-05 | 861 | 126 | 12 | 36931259 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | DCAKD AARS1 FAM114A1 EMC1 ACADL ACADM CYP20A1 GOLT1B GALNT7 PABPC1 SLC2A1 PNPT1 LRPPRC PABPC3 RAB11FIP5 SEC23A | 7.35e-05 | 1451 | 126 | 16 | 30550785 |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 16804161 | ||
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 28608780 | ||
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 7.78e-05 | 4 | 126 | 2 | 9221927 | |
| Interaction | SEC14L3 interactions | 4.38e-06 | 6 | 123 | 3 | int:SEC14L3 | |
| Interaction | TIMM44 interactions | 8.61e-06 | 280 | 123 | 10 | int:TIMM44 | |
| Interaction | DNAL1 interactions | 1.21e-05 | 8 | 123 | 3 | int:DNAL1 | |
| Cytoband | 22q12.2 | 5.86e-07 | 58 | 126 | 5 | 22q12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p12 | 2.76e-04 | 113 | 126 | 4 | chr12p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q12 | 4.97e-04 | 235 | 126 | 5 | chr22q12 | |
| Cytoband | 9q31 | 9.89e-04 | 17 | 126 | 2 | 9q31 | |
| Cytoband | 2p13 | 1.82e-03 | 23 | 126 | 2 | 2p13 | |
| Cytoband | 12p12.1 | 2.89e-03 | 29 | 126 | 2 | 12p12.1 | |
| GeneFamily | SEC14 family|PRELI domain containing | 4.78e-09 | 6 | 78 | 4 | 1063 | |
| GeneFamily | Zinc fingers CW-type | 1.11e-08 | 7 | 78 | 4 | 96 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 1.10e-04 | 4 | 78 | 2 | 1200 | |
| GeneFamily | Protein arginine methyltransferases | 6.49e-04 | 9 | 78 | 2 | 691 | |
| GeneFamily | Acyl-CoA dehydrogenase family | 9.85e-04 | 11 | 78 | 2 | 974 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 4.38e-03 | 23 | 78 | 2 | 523 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | RIPOR2 RAP1GDS1 OXR1 BET1 SRP54 GRIA3 RECQL GOLT1B DNAJC6 AZIN1 LRPPRC BNIP3L DIMT1 CCZ1 UGP2 SCP2 TIMM17A PRKCB SLC25A11 YIPF3 | 1.87e-06 | 1248 | 125 | 20 | M17728 |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_DN | 5.48e-06 | 200 | 125 | 8 | M5118 | |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP | 5.48e-06 | 200 | 125 | 8 | M9051 | |
| Coexpression | GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP | 8.28e-06 | 151 | 125 | 7 | M6498 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | CCZ1B AARS1 RANGAP1 API5 MORC2 CHMP4B MAPK8IP3 LRPPRC BNIP3L DIMT1 CCZ1 ARFGAP3 UGP2 TIMM17A MRPS5 SLC25A11 THRAP3 YIPF3 | 9.84e-06 | 1158 | 125 | 18 | MM1338 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | ACADM OXR1 RECQL GOLT1B BTAF1 API5 TNFRSF17 PNPT1 LRPPRC RSAD2 DDHD1 TIMM17A SEC23A | 2.56e-05 | 687 | 125 | 13 | M41022 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | AARS1 RANGAP1 API5 MORC2 CHMP4B MAPK8IP3 LRPPRC BNIP3L DIMT1 CCZ1 ARFGAP3 UGP2 TIMM17A MRPS5 SLC25A11 THRAP3 YIPF3 | 2.66e-05 | 1129 | 125 | 17 | M42508 |
| Coexpression | GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP | 4.90e-05 | 199 | 125 | 7 | M7274 | |
| Coexpression | GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN | 5.06e-05 | 200 | 125 | 7 | M3377 | |
| Coexpression | GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN | 5.06e-05 | 200 | 125 | 7 | M3264 | |
| Coexpression | NOUZOVA_TRETINOIN_AND_H4_ACETYLATION | 5.36e-05 | 138 | 125 | 6 | M15068 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP | 6.94e-05 | 285 | 125 | 8 | M40879 | |
| Coexpression | ZHENG_CORD_BLOOD_C2_PUTATIVE_BASOPHIL_EOSINOPHIL_MAST_CELL_PROGENITOR | 9.84e-05 | 96 | 125 | 5 | M39211 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-07 | 168 | 126 | 7 | c34dd4a9c54d8e9c8f118e6a3816548890cb0746 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.25e-07 | 180 | 126 | 7 | c0c07937839652e01df10cc1e70aa005800ea6f6 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.25e-07 | 180 | 126 | 7 | 079c199425dd3c220f03c6dca1823946f07580a1 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 8.89e-07 | 182 | 126 | 7 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.91e-07 | 185 | 126 | 7 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-06 | 187 | 126 | 7 | 4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-06 | 193 | 126 | 7 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.56e-06 | 198 | 126 | 7 | 9aee419c59105d8a7ad83bc484b92d30a640666b | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.56e-06 | 198 | 126 | 7 | c4a004f211f72f28aacbb512c6e075cbd049be53 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.61e-06 | 199 | 126 | 7 | 0e696f13c9bd135fbb31368d6dca29897d6a1a25 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid|LPS_only / Treatment groups by lineage, cell group, cell type | 1.61e-06 | 199 | 126 | 7 | 20523dee39a4c5f6423259920f108127b47525c4 | |
| ToppCell | P07-Hematopoietic|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.72e-06 | 138 | 126 | 6 | fb8038393c2b88eb29bd23574c0c6178644900be | |
| ToppCell | P07-Hematopoietic-Immune-immune_cell_unspecified|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.48e-06 | 144 | 126 | 6 | eb057dbdb2a5a2d29b93e5ed5479a3fd1bf3fd26 | |
| ToppCell | P07-Hematopoietic-Immune|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.48e-06 | 144 | 126 | 6 | 962698c5c15bd583fccda0593b7aab5f2eb4bc9f | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-06 | 162 | 126 | 6 | 08ee7ae56e4927874515c47adc86dd845bf29a26 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-06 | 166 | 126 | 6 | 6a65dff1333f39ec8c584e6df04b8c1e7f1c8946 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.43e-06 | 168 | 126 | 6 | 360cd756067c8cfb6a78301674758eb5fac52c23 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.43e-06 | 168 | 126 | 6 | d791116040a9d3ea0485d68c974340116073986b | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 179 | 126 | 6 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 181 | 126 | 6 | 8657d35cd3dff6c89d0fde67d7e7e81e1d6c8884 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 181 | 126 | 6 | f4cd6dba4c04c5cb550f44468eb29c07238fbda4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 181 | 126 | 6 | c7f5d0e5aa2ca6a409957713637e1b37a73ceb60 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 182 | 126 | 6 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 182 | 126 | 6 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 182 | 126 | 6 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-05 | 183 | 126 | 6 | b52d7683dc6652766e814ebe935c264ecd610c4b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-05 | 183 | 126 | 6 | 1d77d8d8c8f78f43dd8864e76f294ee66d4942c2 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 1.37e-05 | 183 | 126 | 6 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-05 | 184 | 126 | 6 | b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-05 | 185 | 126 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.46e-05 | 185 | 126 | 6 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | proximal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.50e-05 | 186 | 126 | 6 | c920dffd24f051b54d8b48f801fffc928d99e135 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.50e-05 | 186 | 126 | 6 | d740aca5dc4240851ba7bc5988c0970d785ad0c2 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.50e-05 | 186 | 126 | 6 | 34ed60e846fd83fab3e28dc9e278bcc4b092a9f0 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.50e-05 | 186 | 126 | 6 | 4ca7f6c043874a0c536f75af5ca24c7c66725e54 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|World / Lineage, cell class and subclass | 1.65e-05 | 189 | 126 | 6 | 826457adac7477102f86aceb97a8b77929b3e6f9 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|World / Lineage, cell class and subclass | 1.70e-05 | 190 | 126 | 6 | 6c7e016a9b425ee9418acd4fe96b9779fe7bd39a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-05 | 191 | 126 | 6 | 81f77bf497b8e0ae0affe7d5f4f00446547229f6 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.80e-05 | 192 | 126 | 6 | 6ace9a34ed264583042156ed61c2cb3504a331d2 | |
| ToppCell | 367C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 192 | 126 | 6 | 877aaf61d8fc40e7013944a0180306dd0bb0557f | |
| ToppCell | 367C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-05 | 193 | 126 | 6 | 940e9a419d0de1f9e72b5cc9c86684057003be58 | |
| ToppCell | MNPs-Dendritic_Cells|MNPs / lung cells shred on cell class, cell subclass, sample id | 1.85e-05 | 193 | 126 | 6 | 0e6b8e179bfe1c6e93137c76c76a91c7782a4989 | |
| ToppCell | 367C-Myeloid-Dendritic|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-05 | 193 | 126 | 6 | 365e831ae6ac67fb36d8d70ef139f4ae7e32c83f | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.96e-05 | 195 | 126 | 6 | 7bb3bdfb8caaae357b1f7841d8d00936c4373dfe | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-05 | 195 | 126 | 6 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 195 | 126 | 6 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.96e-05 | 195 | 126 | 6 | d579150d176e6bd81004b5146de4901ca13a3c3e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 196 | 126 | 6 | 3f065139f76ed048875cd6c03aa02300db2b6574 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-05 | 197 | 126 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.08e-05 | 197 | 126 | 6 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-05 | 197 | 126 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.08e-05 | 197 | 126 | 6 | f870a26f322668781e3d2832c5d9ef2c7c91011f | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-05 | 198 | 126 | 6 | f44eb16695ea52e3f99073f5976590069b1d9c5a | |
| ToppCell | Control-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.14e-05 | 198 | 126 | 6 | 6f7e0b8bc06368d6e7026d69473ddd42dd41cfcb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.14e-05 | 198 | 126 | 6 | 455d55cfdeb8b6b13c289b53e1a5184a574e2e35 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.20e-05 | 199 | 126 | 6 | 8c2ab13b5fffbab3da37041a7000d6537fc4db09 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-05 | 199 | 126 | 6 | 92fdf6e2f0786ab2ab78126e9131a93794168139 | |
| ToppCell | ASK452-Epithelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.20e-05 | 199 | 126 | 6 | e8778d4d2bc7e15b4c7989a93e5808a76738df46 | |
| ToppCell | distal-Hematologic-Classical_Monocyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.20e-05 | 199 | 126 | 6 | cd691f1c2493516d7553cc9a005f6e3b442bdbd5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 199 | 126 | 6 | 87c7b8c77c28f3cfa6d6dddfd00c9d18d116207e | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|Control_saline / Treatment groups by lineage, cell group, cell type | 2.20e-05 | 199 | 126 | 6 | e1240bfcdce76ec018599c50350748f9c7b8fb0e | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | 1592ca96c59eb053d0f0915afb337db9f3a40c91 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | fd1b6db3c62f5a205b769ba0e61433dae6285b67 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.26e-05 | 200 | 126 | 6 | 0b7573ec4e9c67c7d11dd8f5011a70bade30e930 | |
| ToppCell | distal-1-Hematologic-Classical_Monocyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.26e-05 | 200 | 126 | 6 | 3e672dd51ed72e8109691e5ca2fa2801b0539958 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Glia_progenitor_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-05 | 200 | 126 | 6 | c5afba198818d02b4e79956edd7e77ebff74fc2e | |
| ToppCell | COVID-19_Mild-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 2.85e-05 | 125 | 126 | 5 | e58c208b4355252ceabe04a468dd19a1f436182c | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.98e-05 | 134 | 126 | 5 | 7b237690a3765d974f6f813ef2d01154bc23b9d6 | |
| ToppCell | COVID-19_Mild-Myeloid_G-Neutrophil|COVID-19_Mild / Disease group, lineage and cell class | 4.12e-05 | 135 | 126 | 5 | e9eb2bebb6d19c439c83f46c12ca0d676db69de8 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 140 | 126 | 5 | ab90f6f30d89761687f8836e3d327d143ce49ed4 | |
| ToppCell | P03-Hematopoietic|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.07e-05 | 141 | 126 | 5 | 4a856521520ea73291f4730fe94c5de88c2b6f0c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-05 | 143 | 126 | 5 | 360a2ea8b64e3b9084f4c4cb8beb0d44106b9edb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-05 | 143 | 126 | 5 | 605532fc0f32979b306cbb58f8796df7d6b24828 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.42e-05 | 143 | 126 | 5 | 57ee1830d96d73d92b5f83b028592a5d952c6013 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-05 | 143 | 126 | 5 | 5cc59deb5a8af8095c1581e585eaeeecdd938621 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.60e-05 | 144 | 126 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.79e-05 | 145 | 126 | 5 | dc89d817a9bef24a07e992efdab4136f12ceb399 | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar-Club_cell|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.59e-05 | 149 | 126 | 5 | 82edfecb7981d8c336cf9da7aa7e2b3f7a017a3f | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.59e-05 | 149 | 126 | 5 | 14a01ae540db8a350ea26a350b2e6ce6c07639d9 | |
| ToppCell | COVID-19-Mast_cells-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 6.80e-05 | 150 | 126 | 5 | 10697c2d22cb25376827cc7c570ff1adc94c1acd | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.70e-05 | 154 | 126 | 5 | 5967a0a33456d5930fc492a700ebb015ac050abb | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.94e-05 | 155 | 126 | 5 | c648512305166d2a2f0e284c127bc802af908071 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.94e-05 | 155 | 126 | 5 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.44e-05 | 157 | 126 | 5 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-05 | 158 | 126 | 5 | 2ef43d14ee65d004dc62c12ff209bbe12e4db681 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.69e-05 | 158 | 126 | 5 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.22e-05 | 160 | 126 | 5 | 61eefe84c8e30d8a3812f5b48d26ed01739aa1ce | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.50e-05 | 161 | 126 | 5 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 164 | 126 | 5 | 15d52666e5150e7c34b1f641a937fb2d5e8aaf8a | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 164 | 126 | 5 | d622f0d8d8bad48dfdf160ec63c545df192637a9 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 164 | 126 | 5 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | Adult-Immune-dendritic_cell|Adult / Lineage, Cell type, age group and donor | 1.07e-04 | 165 | 126 | 5 | 073f52698dac1fe4edd7410865f81b30e1c7196a | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.07e-04 | 165 | 126 | 5 | b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.13e-04 | 167 | 126 | 5 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 167 | 126 | 5 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 168 | 126 | 5 | 943687a33fffd7e19d906b9dd385a126bcea109a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 168 | 126 | 5 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 168 | 126 | 5 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | Control-Hematopoietic_Meg-Ery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 169 | 126 | 5 | c2e2a7b89fe4a64d79efafdec037c4104f433061 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 169 | 126 | 5 | f195467438c589f87224bde7da720dea072d110c | |
| Drug | Vitamin E | 1.77e-07 | 10 | 125 | 4 | DB00163 | |
| Drug | palmitate | GPLD1 ACADL ACADM ANXA4 STEAP4 APOB FABP6 LIPE SLC27A1 SCP2 SMS SEC14L2 | 8.84e-07 | 367 | 125 | 12 | CID000000985 |
| Drug | carnitine | ACADL ACADM OXCT2 STEAP4 POU2F1 APOB LIPE SLC22A16 SLC27A1 SEC14L2 | 2.11e-06 | 265 | 125 | 10 | CID000000085 |
| Drug | oleoyl coenzyme A | 4.04e-06 | 118 | 125 | 7 | CID000000966 | |
| Drug | 3,4-dioctylphthalic acid | 6.24e-06 | 126 | 125 | 7 | CID005743034 | |
| Disease | immune system disease (implicated_via_orthology) | 5.07e-05 | 3 | 122 | 2 | DOID:2914 (implicated_via_orthology) | |
| Disease | bilirubin measurement | SOX5 FAM114A1 HLA-DQB2 RECQL GOLT1B APOB TAC4 HOOK1 SLC22A16 | 9.60e-05 | 442 | 122 | 9 | EFO_0004570 |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.96e-04 | 128 | 122 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.96e-04 | 128 | 122 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.96e-04 | 128 | 122 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.96e-04 | 128 | 122 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.96e-04 | 128 | 122 | 5 | C0007134 | |
| Disease | Global developmental delay | 2.34e-04 | 133 | 122 | 5 | C0557874 | |
| Disease | pneumocystosis (biomarker_via_orthology) | 2.52e-04 | 6 | 122 | 2 | DOID:11339 (biomarker_via_orthology) | |
| Disease | gamma-glutamylglycine measurement | 3.51e-04 | 7 | 122 | 2 | EFO_0800670 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.84e-04 | 148 | 122 | 5 | C0279702 | |
| Disease | reticulocyte measurement | CCZ1B OXR1 HLA-DQB2 TAC4 PABPC1 SLC2A1 AZIN1 BNIP3L HOOK1 SLC22A16 RCL1 SEC14L4 THRAP3 | 4.28e-04 | 1053 | 122 | 13 | EFO_0010700 |
| Disease | ceramide measurement | 4.48e-04 | 235 | 122 | 6 | EFO_0010222 | |
| Disease | Dystonia | 4.55e-04 | 86 | 122 | 4 | C0013421 | |
| Disease | Malignant neoplasm of breast | ABCA3 ACADM IDO1 POU2F1 RECQL PABPC1 SLC2A1 LIPE HOOK1 ARFGAP3 SCP2 UTP20 ZFYVE26 | 5.15e-04 | 1074 | 122 | 13 | C0006142 |
| Disease | clinical treatment | 6.55e-04 | 41 | 122 | 3 | EFO_0007056 | |
| Disease | erythrocyte measurement | 7.17e-04 | 257 | 122 | 6 | EFO_0005047 | |
| Disease | non-melanoma skin carcinoma | 8.40e-04 | 265 | 122 | 6 | EFO_0009260 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 9.55e-04 | 181 | 122 | 5 | DOID:684 (is_implicated_in) | |
| Disease | hemolysis | 9.79e-04 | 47 | 122 | 3 | EFO_0009473 | |
| Disease | phenylacetylglutamine measurement | 1.09e-03 | 12 | 122 | 2 | EFO_0021013 | |
| Disease | rheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis | 1.28e-03 | 13 | 122 | 2 | EFO_0000685, EFO_0006527, EFO_0009459 | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 1.49e-03 | 14 | 122 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | response to statin | 1.63e-03 | 56 | 122 | 3 | GO_0036273 | |
| Disease | acylcarnitine measurement | 1.94e-03 | 127 | 122 | 4 | EFO_0005059 | |
| Disease | colorectal mucinous adenocarcinoma | 1.96e-03 | 16 | 122 | 2 | EFO_0009361 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.96e-03 | 16 | 122 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | response to ketamine | 2.96e-03 | 69 | 122 | 3 | EFO_0009748 | |
| Disease | obsolete_red blood cell distribution width | SLC17A2 FLT3 FAM114A2 APOB TAC4 SLC2A1 BNIP3L HOOK1 SLC22A16 RCL1 CHSY3 ATP2B3 SEC14L4 | 3.85e-03 | 1347 | 122 | 13 | EFO_0005192 |
| Disease | carnitine measurement | 3.89e-03 | 76 | 122 | 3 | EFO_0010469 | |
| Disease | frailty measurement | 4.05e-03 | 23 | 122 | 2 | EFO_0009885 | |
| Disease | platelet-to-lymphocyte ratio | 4.07e-03 | 363 | 122 | 6 | EFO_0008446 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FDSTTGFLGKTMGKL | 71 | O15155 | |
| DGLMSFAGGKLLIVG | 126 | O43315 | |
| DGNMGLGFQGEKGVK | 216 | Q14031 | |
| GELEFMGFPKGKKGS | 246 | Q14031 | |
| KGALVTGAMAFVGGL | 41 | Q9NSK7 | |
| GKKNVDSDRLGMGFG | 296 | Q9NP61 | |
| AGTGILSMFAKKAGA | 186 | Q6P2P2 | |
| SLFLVENGMKGFIKG | 231 | P28330 | |
| IGGEEGNMKFGTTLK | 161 | O14977 | |
| GFNGAGKTTTFKMLT | 1416 | Q99758 | |
| FGGFKMSGNGRELGE | 466 | P00352 | |
| GTGILSMFAAKAGAK | 121 | Q9NR22 | |
| LLSIFKMDAKGTLGG | 121 | Q9BZZ5 | |
| KMDAKGTLGGLFSQI | 126 | Q9BZZ5 | |
| MSVFGKLFGAGGGKA | 1 | Q9H444 | |
| NVLIGDGAGFKVAMG | 261 | P11310 | |
| DGAGFKVAMGAFDKT | 266 | P11310 | |
| MATKGGTVKAASGFN | 1 | P09525 | |
| IDKEGTGKMNFGDFL | 76 | P41208 | |
| MAEGKAGGAAGLFAK | 1 | Q9UBW5 | |
| ALKKADVGFAMGIAG | 801 | Q16720 | |
| KGGDKVLMTCVGIGF | 351 | Q9Y2P8 | |
| TFTGGAKGLMDIFGK | 131 | Q8NHQ8 | |
| ELKLNNCGMGIGGGK | 146 | P46060 | |
| DLGSLGKMGKAKGFF | 221 | Q9BXF6 | |
| GGDTLEGSMAQLKKG | 626 | P26045 | |
| KVMTDESGKSKGFGF | 221 | P11940 | |
| NGLKSGSMRIGKDFI | 101 | Q86VD1 | |
| AKGTGGTDLMNFLKT | 376 | P14902 | |
| PGGGLMGKFVLKASL | 221 | O43474 | |
| DTQKIGMGLTGFGVF | 6 | Q9Y3E0 | |
| VSKMLGTGKLGFSFV | 1131 | Q9UPT6 | |
| GFSKLGKSFEMLILG | 111 | P11166 | |
| AQSKMLSGIGGFVLG | 226 | P05538 | |
| DTMKVGGNLDSKGYG | 751 | P42263 | |
| DTMKVGGNLDSKGYG | 741 | P48058 | |
| GNGFKSGSMRLGKDA | 101 | Q14149 | |
| LSKNGMVAKLGDFGI | 136 | Q6P3R8 | |
| TDKKIGFLGLGLMGS | 266 | Q49A26 | |
| DKGQGGFTGFLVSML | 341 | Q9H6R4 | |
| SMAKGDFDNLSGKGK | 211 | Q9NX36 | |
| LAMGKFFKGLASSGA | 1286 | Q6ZR08 | |
| KLGFTQGDVGLAMGK | 216 | P09086 | |
| GIGAFRFMLESNKGK | 211 | Q8IVB5 | |
| GDIEGASKILGFMKT | 211 | P42704 | |
| DFNFLMVLGKGSFGK | 341 | P05771 | |
| PKMLAGFIGVDGGKN | 81 | Q8NGQ2 | |
| KDGHGEAIMFKGLGG | 506 | Q9Y2J8 | |
| KSVKFLFGGLAGMGA | 21 | Q02978 | |
| SKAFEIMLAAGEGKG | 1331 | O75161 | |
| KVMTDESGKSKGFGF | 221 | Q9H361 | |
| KLGFTQGDVGLAMGK | 301 | P14859 | |
| GNGLKSGSMRIGKDF | 101 | Q9Y6X9 | |
| KVKGFGGAMTDAAAL | 116 | P04062 | |
| IKGEGDMAKALGTCG | 231 | P0C7T3 | |
| FIKGDMDSLAFGGGG | 816 | Q8N573 | |
| TQGMFDKNGIKGGLK | 101 | Q9H7U1 | |
| EFGKVLGSGAFGKVM | 611 | P36888 | |
| VLTAKGMALFGEGKA | 3001 | P04114 | |
| GMALFGEGKAEFTGR | 3006 | P04114 | |
| GGSGFLKSGGEMLKV | 281 | Q9P2D3 | |
| EILKAHGKSGGKMGD | 311 | O14981 | |
| MFLVGLTGGIASGKS | 1 | Q8WVC6 | |
| IDSMGKTNGGFVELG | 546 | Q86SF2 | |
| GGKTFKATVQMEGGK | 76 | P51161 | |
| ALGAGTALLGKEGAM | 121 | Q99807 | |
| KLFNGTFLKAMEDGG | 146 | P86791 | |
| LGDESMQKLFEGGKG | 301 | P52306 | |
| GLFDMVKGGAGRLFS | 21 | O75061 | |
| KSGAMKKGGIFSAEF | 171 | O60238 | |
| KLFNGTFLKAMEDGG | 146 | P86790 | |
| AQLVLKKGFGGTAGM | 301 | Q13443 | |
| KKGFGGTAGMAFVGT | 306 | Q13443 | |
| KGSGFGAATKAMCIG | 126 | Q8NDY3 | |
| SGGLDALEFIGKKTM | 171 | Q9NRY5 | |
| LSAKGMSLGVEGFAG | 451 | O75342 | |
| GEFGKKADGLLGMFL | 471 | Q8N766 | |
| ASIGKGLGGMLFSRF | 751 | Q8NEL9 | |
| FQKLGMESRLVSGGG | 676 | Q9UJC3 | |
| GKGFLDGSLDKNMTR | 206 | Q6UW02 | |
| LPSGKGMFGNDGVKV | 16 | Q30KP8 | |
| LGKGGFGEVSACQMK | 196 | Q15835 | |
| GADVGFGIFLKTKMG | 311 | O76054 | |
| GADIGFGVFLKTKMG | 311 | Q9UDX4 | |
| GGDIGFGVFLKTKMG | 311 | Q9UDX3 | |
| GGDIGFGVFLKTKMG | 311 | B5MCN3 | |
| SKIGGKMLLGFGILG | 131 | Q9NRA2 | |
| ELKSAGGLMFNTGIG | 21 | Q9UNQ2 | |
| GGMVAQGVKLGFKGK | 251 | Q05469 | |
| GGLDALEFIGKKTMN | 226 | Q8IWE2 | |
| GGFGISMVKVFLISG | 156 | O95222 | |
| GGGGGMAKASAAELK | 51 | Q8NEY1 | |
| MAEKQKALFTRSGGG | 271 | Q9H0K4 | |
| KGAAGFSIGKATDRM | 251 | P82675 | |
| ALFMTVDKGSFGKGN | 546 | O75691 | |
| FMLGAKADGETILKG | 11 | P52788 | |
| GGLGISIKGGKENKM | 121 | Q13884 | |
| KVKKMGLGHEQGFGA | 6 | Q9UGI8 | |
| GIKGLFKGGDMSKNV | 436 | P61011 | |
| LLKEAGMEKINFSGG | 111 | Q8WXG1 | |
| TAMVGKFAIGAAFGL | 446 | Q86VW1 | |
| TLMFVGGLGGQIKKS | 2246 | P25391 | |
| FGNGFKSGSMRLGKD | 121 | Q8TE76 | |
| VKMSKFGGGIGVPAK | 801 | Q8IZU2 | |
| GDMDFKIAGTNKGIT | 541 | Q8TCS8 | |
| VLALGFEKMSKGSLG | 116 | P22307 | |
| KDISDGATVMIGGFG | 51 | Q9BYC2 | |
| LGEFSIKMKGLAGFA | 201 | Q9Y4F9 | |
| GQFKMGFGGTLEIKT | 396 | Q15436 | |
| VGGIMTGEKKDGFSD | 516 | Q14246 | |
| LKILSSFQGAKEMGG | 601 | Q70JA7 | |
| GKEVFLVMPTGGGKS | 106 | P46063 | |
| KKGFDFTLMVAGESG | 26 | Q8WYJ6 | |
| VKLNGGLGTSMGCKG | 111 | Q16851 | |
| GSFSDTGLGDGKMKS | 376 | Q9Y2W1 | |
| INLFMGSEKGKAGTA | 136 | Q7Z3J2 | |
| KSQGKGAGGEDLIML | 451 | P49588 | |
| KGEAGARFLMAGVGL | 466 | Q8N271 | |
| LGTSGAKALIFGGEM | 171 | Q6PCB7 | |
| FGAKKMLGAGLLISS | 116 | O00624 | |
| FTISGDKAMGKLGTS | 636 | P80108 | |
| GTGDFGRSLGLKMLQ | 26 | Q687X5 | |
| FTMGTIGGGIFQAIK | 21 | Q99595 | |
| DGEFLGMKGFKGQLS | 76 | Q9GZM5 | |
| GLEKDGSFGEGLTMK | 641 | Q9ULT0 | |
| KLLAMGSGNFGEIKG | 176 | P35711 | |
| FEGLMGTIKSKVSGG | 121 | Q96J77 | |
| KDEFKNTGSGLLGMA | 86 | Q02223 | |
| KTGKASQFFGLMGKR | 56 | Q86UU9 | |
| KVMLGGKNVEDGFGI | 2376 | Q68DK2 | |
| GGLQMKGDIFDGTSF | 2756 | Q15911 | |
| KFAGTLSDGLGKTMD | 4111 | Q5THJ4 |